Professional Documents
Culture Documents
I,IME HA JIEKOT
.,
KBAJII.TTATI,IBEH II KBAHTI'TATHBEH COCTAB
Elna ra6lera coapxn 500 mg aqerlqurrrll.tJrHa KrcennHa,
Ta6nera
Fenr.r, orpyrarl ra6reru co Bayer-o8 Kpcr Ha eAHara crpaua n o:rarara Aspirin 0.5 Ha Apyrara.
4.3 Konrpann,quxaqtrx
Bo cle4naee c,ryvar, Acnnpnx 500 ra6,rerr Moxe !a ce ynorpe6yBaar caMo aKo pll3ltKor lt
KopHcra oA rlrauara ynorpe6a BHr..rMarerHo ce trpoqeHerlt:
- Hcrorpeueno .neKyBalr,e co aHTnKoafynaHTHH JreKoBx
- facrpoturecrtHarHfi qr.rpeBx (xponuruu Hnu noBTopnxBlr ula ncroprja ua rpaape*e)
- HapyueHa Qyuxqrja xa qpuuor 1po6 u 6y6pe:tre
- flpevyacrarrelHocr Ha .{pyrfi agraat$lauaropxu/axtrpeavartvHn reKoBr r{nl-t .{pyfll
anepfeHcKli cyncTaHuHH
.....'
-,':;
Acnrprro ra6,'rerr-r 500 mg Summary of Product Characteristics
xeMocTa3a
3roleuex pH3t K oA KpBapeH,e nopaAN uxxn6upaxara arperaqaja xa rpov6oqurrre
fi noBpeAa
Ha srror
Ha croMaKor H AyoAeHyMor. Aqeralca,rrqulaa KlrcerrHa rh enlMl.tHupa opaflHfiTe
KoafynaHTH Bp3aHH 3a npoTelHHTe npeKy cantlu]rnaTtlTe.
.Ilurorcnu
3roleuesa xosrleHrpaqaja Ha AnroKclrH Bo nJIa3Ma KoHueH.rpaqxHTe, nopaafi HaMa,leHa
ceKpellrja HH3 6y6pcrare.
np.rlHcynlH,cy.rrQouu,'rypea
4!r!a4g6
l oJreMH ro3r.r Ha arrerhJtcannultrHa KucenHHa
ro :ajaxuysaar xunorJrHKeMficxl,ror e$err ua
auru-laja6ernqare, nopaar.r lej:nHoro xrnorrrKeMHcKo gejcrao n ja e,ravlHnpaar
cy,rQorr.r.nypeara oA nporeliHcKara BpcKa np€Ky caJlfiuhrarfiTe.
Ba.nnDoaqHa rnceltta
flouecryaarrero oA nporer.{HcKara BpcKa ao nJrar}Mara ja rrolelryaa roKcHqHocra Ha
Bannpol-tqHaTa KHceJItlHa.
AIKoXoI
Aqerrrcalu(n.nnara KrrceJruHa Ir aJrKoxoJror rMaar aalrrnBeH e$err, ruro ro 3roJleMyBa
HeTaTHBHOTO Bnr.{aHhe Ha racTpo-lrHTecTHHarHara MyKo3a h fo npoaonxyBa EpeMeTo Ha
KpBapelbe.
IacrponrrecrnxarHrr HapytuyBarsa
9ecrr ce mcrpoxHTecrrrHiulHHTe nopeMerysalla KaKo onlrrrr 3Haufi t-t cr.tMrrroMH ta lncnenctja
a 6orxa Bo croMaKor H noBp€MeH[ ce racrpor4HTecrxHillrHl{Te aocnaleHxja,
racTpouHTecTfiHarHr{Te qnpeBll, txTo MHofy peTKo Moxe aa .qoBeaaT Io KpBaperbe H
nepQopaurja, co la6oparoprcru xJll.lHHqKfi 3Haql ll ct.rMIToMH.
4.9 IIpe4o:npa*e
huroxcrxaqrjara co caruuhrarn (> 100 mg/kg/Aeu noae(e oA ABa AeHa Moxe .Ia AoBeAe Ao
LlHToKcHKaUllja) Moxe Aa 6u1e peaynrar Ha xpoHuqHa repaneBTcKa ynorpe6a, rHroxclrxaqaja
I-ln]r xrr8or-3arpo3yBaqKa aK]"rHa xHToKcr{Karltija (npelo3xpa}be), KaKo pgynrar Ha HeHaMepHo
npero3[pa]be. np. Kaj,qeua xnl HeHaMepHa uHroxclxaquja.
ucra6orrqna auuaoga
Tpecra Mopa ra ce rouner:upa ry6envro
HA TEqNOCT Ti ETEKII)OII{IN
Pecn uparopuo
nopeMeTyBarre:
Xtneprerrr.uraqnj a,
HexapAHoreH
6eroapo6ex eaeu,
HeHa.(eeH pecIrrjpaTopeH
nperas, cydorauria
KapanoBacxylapHo llp. upouera ra xpaen npmncor(,
nop€MgryBaBe: EKT
,ancpmMr.!4,
xr.rneprexruja, renaaeen
npernx na pa6orara ra
cpueTo
fy6e*e na revaocr I flp, xrnouaxeulja, Mopa aa ce |(oMneH3rlpa ry6€rbsro
eneKTponnTll: xnnepxarpeuaja, xnnorarpeuuja, HA T€qHOCT N EIEXTOOI]IT'I
aexraparaunj a, rapyuena 6y6pexaa rlyHxurja
onuf wula rtru aypu tr
6y6p€xHa
uacyduuxeruuia
Ilopeueryran e aa Xuneprrnxeurja, xanor.nuxeulja
uera6onr:uot aa (oco6eHo Kaj aeua), 3roreMeHh
rnyKo3a, KeTo3a BPCAHOCTH HA KETOH
3yerre ao yurre,
nop€MeTyBabe Ba
crvxm
facrponHTegrriHarHo
xDBaDer6e
Xenarolourxt IIp. npoao,rxero nporpou6rxcxo
nopeMgTyBarba: BpeMe, xunonporpou6uteuuja
uxxr6nqnja Ha
rpou6ouarr xoja oona
,aoxoarylonarria
Heapororuxo
nopeMgryBaEe:
TOXCtqHa
eaueQaronarnja r
aenpecnja ua I{HC uro
,qo8e,qyBa,[o nfiapnBJa,
xoHoy3rja, xoMa H
rDqeBt
5. OAPMAKOJIOUKI,I TIOAATOIII
Hcro raxa ce Koprlcrrl 3a neKyoa}le Ha aK}"THx r.t xpoHlqHr.t uxQlavaropan 6olecru, raxo nro
ce peBMaroHAHlror aprprrrllc, ocreoaprparacor H aHKllJto3HHor cnoH,[l.lJlltrnc. Kaj oBhe
cocroj6u BorraBHo ce Koprcrar roneMrl ro3r.r, oA 4 Ao 8 g au€ano, roaereHfi ao HeKoJrKy
eallHeqHI-t ao3H.
Auerlca,ruullrtsara KHceJIxHa e,{eranHo npoyqeHa r.tH Br.rrpo l.r r.rH Bl.rBo Bo o,rlHoc Ha nejlrHuor
uyraren norexqtja.n. Her.ra peneBaHTHH ,qoKa3x 3a MyrareHHor noreuqnja:r, l4croro aaxa n la
KapqHHorcHfiTe cry4lll. CaluqalarHTe noKzDKa!'re reparoreHx eQerru xaj Hexojll(y xr.tBorr,rHcKl.l
BHAOBH Kaj CryAHH CO XI'rBOTHlr. HaMa,'leHa nun.naxraqrj4 eu6pnororccnuult x
$erotorccnvHu
e$erru, xaxo H HapyueHa c,loco6rocr:a yrerre ce onHruaHlr nocne npeHararHo H3noxyBarhe.
t,
t- Acnnplcro n6nan 500 mg Summary of ProduC Characfcrisrics
I
6 OAPMAT{EBTCISTOAATOIE
I 6l Jlxcrr re erclltrf,escf,
I{elyaosen npae
I 6.2
Ilqesxapen cxpo6
lfrxornlrr6narosr
I He e nognara
g.AATYM HA trPBOTO
OAOBPEHITE 3A CTABAEE HA JIEKOT
AATYM HA trOCNEAIIOTO OEEOBEIIOOI BO IIPOMET II
I
3l.0E.2009
I
I
't
I
"l